A novel scheme of dystrophin disruption for the progression of advanced heart failure

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1751, Issue 1, 2005, Pages 73-81

  Kawada, Tomie ^a   Masui, Fujiko ^b   Tezuka, Asaki ^b   Ebisawa, Takashi ^b   Kumagai, Hiroyuki ^c   Nakazawa, Mikio ^d   Toyo Oka, Teruhiko ^b,c  

^a NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c TOHOKU UNIVERSITY   (Japan)

^d NIIGATA UNIVERSITY   (Japan)

Author keywords

Sarcoglycan (SG); Calpain; Dystrophin; Gene therapy; Heart failure; Proteolysis

Indexed keywords

CALPAIN; CALPASTATIN; DELTA SARCOGLYCAN; DYSTROPHIN; EVANS BLUE; ISOPRENALINE; PROTEINASE; SARCOGLYCAN; UNCLASSIFIED DRUG;

ACUTE HEART FAILURE; CONFERENCE PAPER; CONGENITAL HEART DISEASE; CONGESTIVE CARDIOMYOPATHY; DISEASE COURSE; GENE THERAPY; HAMSTER; HEART FAILURE; HEART MUSCLE CELL; HEART MUSCLE FIBER MEMBRANE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MEMBRANE PERMEABILITY; METABOLISM; MUSCLE FIBRIL; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; SARCOLEMMA; SURVIVAL; UPREGULATION; WESTERN BLOTTING;

ANIMALS; CALCIUM-BINDING PROTEINS; CALPAIN; CARDIOMYOPATHY, DILATED; CELL MEMBRANE PERMEABILITY; CRICETINAE; DEPENDOVIRUS; DISEASE MODELS, ANIMAL; DYSTROPHIN; ENZYME ACTIVATION; GENE THERAPY; HEART FAILURE, CONGESTIVE; ISOPROTERENOL; MESOCRICETUS; MODELS, BIOLOGICAL; RATS; SARCOGLYCANS; SARCOLEMMA;

ANIMALIA; CRICETINAE;

EID: 22744444453     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2005.01.001     Document Type: Conference Paper

References (44)

1. M. Packer, C.M. O'Connor, J.K. Ghali, M.L. Pressler, P.E. Carson, R.N. Belkin, A.B. Miller, G.W. Neuberg, D. Frid, J.H. Wertheimer, A.B. Cropp, and D.L. DeMets Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group N. Engl. J. Med. 335 1996 1107 1114
2. J.N. Cohn, and G. Tognoni A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure N. Engl. J. Med. 345 2001 276
3. M. Packer, A.J. Coats, M.B. Fowler, H.A. Katus, H. Krum, P. Mohacsi, J.L. Rouleau, M. Tendera, A. Castaigne, E.B. Roecker, M.K. Schultz, D.L. DeMets Carvedilol Prospective Randomized Cumulative Survival Study Group Effect of carvedilol on survival in severe chronic heart failure N. Engl. J. Med. 344 2001 1651 1658
4. P.A. Poole-Wilson, K. Swedberg, J.G. Cleland, A. Di Lenarda, P. Hanrath, M. Komajda, J. Lubsen, B. Lutiger, M. Metra, W.J. Remme, C. Torp-Pedersen, A. Scherhag, A. Skene Carvedilol or Metoprolol European Trial Investigators Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomized controlled trial Lancet 362 2003 7 13
5. V.V. Michels, P.P. Moll, F.A. Miller, A.J. Tajik, J.S. Chu, D.J. Driscoll, J.C. Burnett, R.J. Rodeheffer, J.H. Chesebro, and H.D. Tazelaar The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy N. Engl. J. Med. 326 1992 77 82
6. J.A. Towbin, and N.E. Bowles Molecular diagnosis of myocardial disease Expert Rev. Mol. Diagn. 2 2002 587 602
7. J.G. Seidman, and C. Seidman The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms Cell 104 2001 557 567
8. T. Toyo-oka, T. Kawada, H. Xi, M. Nakazawa, F. Masui, C. Hemmi, J. Nakata, A. Tezuka, K. Iwasawa, M. Urabe, J. Monahan, and K. Ozawa Gene therapy prevents disruption of dystrophin-related proteins in a model of hereditary dilated cardiomyopathies in hamster Heart Lung Circ. 11 2002 174 181
9. F. Homburger, J.R. Baker, C.W. Nixon, and R. Whitney Primary, generalized polymyopathy and cardiac necrosis in an inbred line of Syrian hamsters Med. Exp. 6 1962 339 345
10. E. Bajusz, J.R. Baker, and C.W. Nixon Spontaneous, hereditary myocardial degeneration and congestive heart failure in a strain of Syrian hamsters Ann. N.Y. Acad. Sci. 156 1956 105 129
11. A. Sakamoto, K. Ono, M. Abe, G. Jasmin, T. Eki, Y. Murakami, T. Masaki, T. Toyo-oka, and F. Hanaoka Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, δ-sarcoglycan, in hamster: an animal model of disrupted dystrophin-associated glycoprotein complex Proc. Natl. Acad. Sci. U. S. A. 94 1997 13873 13878
12. V. Nigro, Y. Okazaki, A. Belsito, G. Piluso, Y. Matsuda, L. Politan, G. Nigro, C. Ventura, C. Abbondanza, A.M. Molinari, D. Acampora, M. Nishimura, Y. Hayashizaki, and G.A. Puca Identification of the Syrian hamster cardiomyopathy gene Hum. Mol. Genet. 6 1997 601 607
13. G.F. Cox, and L.M. Kunkel Dystrophies and heart disease Curr. Opin. Cardiol. 12 1997 329 343
14. K.H. Holt, L.E. Lim, V. Straub, D.P. Venzke, F. Duclos, R.D. Anderson, B.L. Davidson, and K.P. Campbell Functional rescue of the sarcoglycan complex in the BIO 14.6 hamster using delta-sarcoglycan gene transfer Mol. Cell 1 1998 841 848
15. M.D. Henry, and K.P. Campbell Dystroglycan inside and out Curr. Opin. Cell Biol. 11 1999 602 607
16. T. Kawada, Y. Nakatsuru, A. Sakamoto, T. Koizumi, W.S. Shin, Y. Okai-Matsuo, J. Suzuki, Y. Uehara, M. Nakazawa, H. Satoh, T. Ishikawa, and T. Toyo-oka Strain- and age-dependent loss of sarcoglycan complex in cardiomyopathic hamster hearts and its reexpression by δ-sarcoglycan gene transfer in vivo FEBS Lett. 458 1999 405 408
17. S. Tsubata, K.R. Bowles, M. Vatta, C. Zintz, J. Titus, L. Muhonen, N.E. Bowles, and J.A. Towbin Mutations in the human δ-sarcoglycan gene in familial and sporadic dilated cardiomyopathy J. Clin. Invest. 106 2000 655 662
18. R. Fadic, Y. Sunada, A.J. Waclawik, S. Buck, P.J. Lewandoski, K.P. Campbell, and B.P. Lotz Brief report: deficiency of a dystrophin-associated glycoprotein (adhalin) in a patient with muscular dystrophy and cardiomyopathy N. Engl. J. Med. 334 1996 362 366
19. R. Barresi, C. Di Blasi, T. Negri, R. Brugnoni, A. Vitali, G. Felisari, A. Salandi, S. Daniel, F. Cornelio, L. Morandi, and M. Mora Disruption of heart sarcoglycan complex and severe cardiomyopathy caused by a sarcoglycan mutations J. Med. Genet. 37 2000 102 107
20. L. Politano, V. Nigro, L. Passamano, V. Petretta, L.I. Comi, S. Papparella, G. Nigro, P.F. Rambaldi, P. Raia, A. Pini, M. Mora, M.A. Giugliano, M.G. Esposito, and G. Nigro Evaluation of cardiac and respiratory involvement in sarcoglycanopathyies Neuromuscul. Disord. 11 2001 178 185
21. D. Fatkin, C. MacRae, T. Sasaki, M.R. Wolff, M. Porcu, M. Frenneaux, J. Atherton, H.J. Vidaillet Jr., S. Spudich, U. De Girolami, J.G. Seidman, C. Seidman, F. Muntoni, G. Muehle, W. Johnson, and B. McDonough Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease N. Engl. J. Med. 341 1999 1715 1724
22. T. Kawada, A. Sakamoto, M. Nakazawa, M. Urabe, F. Masuda, C. Hemmi, Y. Wang, W.S. Shin, Y. Nakatsuru, H. Sato, K. Ozawa, and T. Toyo-oka Morphological and physiological restorations of hereditary form of dilated cardiomyopathy by somatic gene therapy Biochem. Biophys. Res. Commun. 284 2001 431 435
23. T. Kawada, M. Nakazawa, S. Nakauchi, K. Yamazaki, R. Shimamoto, M. Urabe, J. Nakata, C. Hemmi, F. Masui, T. Nakajima, J. Suzuki, J. Monahan, H. Sato, T. Masaki, K. Ozawa, and T. Toyo-oka Rescue of hereditary form of dilated cardiomyopathy by rAAV-mediated somatic gene therapy Proc. Natl. Acad. Sci. U. S. A. 99 2002 901 906
24. D.J. Blake, A. Weir, S.E. Newey, and K.E. Davies Function and genetics of dystrophin and dystrophin-related proteins in muscle Physiol. Rev. 82 2002 291 329
25. G. Bates Huntingtin aggregation and toxicity in Huntington's disease Lancet 361 2003 1642 1644
26. T. Toyo-oka, T. Kawada, J. Nakata, H. Xie, M. Urabe, F. Masui, T. Ebisawa, A. Tezuka, K. Iwasawa, T. Nakajima, Y. Uehara, H. Kumagai, S. Kostin, J. Schaper, M. Nakazawa, and K. Ozawa Translocation and cleavage of myocardial dystrophin as a common pathway to advanced heart failure: a scheme for the progression of cardiac dysfunction Proc. Natl. Acad. Sci. U. S. A. 101 2004 7381 7385
27. H. Xi, W.S. Shin, J. Suzuki, T. Nakajima, T. Kawada, Y. Uehara, M. Nakazawa, and T. Toyo-oka Dystrophin disruption might be related to myocardial cell apoptosis caused by isoproterenol J. Cardiovasc. Pharmacol. 36 Suppl. 2 2000 S25 S29
28. H. Kawaguchi, W.S. Shin, Y.P. Wang, M. Inukai, M. Kato, Y. Matsuo-Okai, A. Sakamoto, Y. Uehara, Y. Kaneda, and T. Toyo-oka In vivo gene transfection of human endothelial cell nitric oxide synthase in cardiomyocytes causes apoptosis-like cell death, Identification using Sendai virus-coated liposomes Circulation 95 1997 2441 2447
29. X. Xiao, I. Li, and R.I. Samulski Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector J. Virol. 70 1996 8098 8108
30. E.C. Svensson, D.J. Marshall, K. Woodard, H. Lin, F. Jiang, L. Chu, and J.M. Leiden Efficient and stable transduction of cardiomyocytes after intramyocardial injection or intracoronary perfusion with recombinant adeno-associated virus vectors Circulation 99 1999 201 205
31. J.A. Wagner, T. Reynolds, M.L. Moran, R.B. Moss, J.J. Wine, T.R. Flotte, and P. Gardner Efficient and persistent gene transfer of AAV-CFTR in maxillary sinus Lancet 351 1998 1702 1703
32. M.A. Kay, C.S. Manno, M.V. Ragni, P.J. Larson, L.B. Couto, A. McClelland, B. Glader, A.J. Chew, S.J. Tai, R.W. Herzog, V. Arruda, F. Johnson, C. Scallan, E. Skarsgard, A.W. Flake, and K.A. High Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector Nat. Genet. 24 2000 257 261
33. M.J. Sole Hamster cardiomyopathy: understanding the pathogenesis of heart failure Hamst. Inf. Serv. 8 1986 3 6
34. J.P. Greelish, L.T. Su, E.B. Lankford, J.M. Burkman, H. Chien, S.K. Koenig, I.M. Mercier, P.R. Desjardins, M.A. Mitchell, X.G. Zheng, J. Leferovich, G.P. Gao, R.J. Balice-Gordon, J.M. Wilson, and H.H. Stedman Stable restoration of the sarcoglycan complex in dystrophic muscle perfused with histamine and a recombinant adeno-associated viral vector Nat. Med. 5 1999 439 443
35. J. Li, D. Dressman, Y.P. Tsao, A. Sakamoto, E.P. Hoffman, and X. Xiao rAAV vector-mediated sarcogylcan gene transfer in a hamster model for limb girdle muscular dystrophy Gene Ther. 6 1999 74 82
36. D.S. Kahn, G. Rona, and C.I. Chappel Isoproterenol-induced cardiac necrosis Ann. N.Y. Acad. Sci. 156 1969 285 293
37. S.S. Gottlieb, R.J. McCarter, and R.A. Vogel Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction N. Engl. J. Med. 339 1998 489 497
38. M.J. Lohse, S. Engelhardt, and T. Eschenhagen What is the role of β-adrenergic signaling in heart failure? Circ. Res. 93 2003 896 906
39. T.M. Olson, V.V. Michels, S.N. Thibodeau, Y.S. Tai, and M.T. Keating Actin mutations in dilated cardiomyopathy, a heritable form of heart failure Science 280 1998 750 752
40. C. Badorff, G.H. Lee, B.J. Lamphear, M.E. Martone, K.P. Campbell, R.E. Rhoads, and K.U. Knowlton Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy Nat. Med. 5 1999 266 267
41. H. Yoshida, M. Takahashi, M. Koshimizu, K. Tanonaka, R. Oikawa, T. Toyo-oka, and S. Takeo Decrease in sarcoglycans and dystrophin in failing heart following acute myocardial infarction Cardiovasc. Res. 59 2003 419 427
42. J.K. Gwathmey, L. Copelas, R. MacKinnon, F.J. Schoen, M.D. Feldman, W. Grossman, and J.P. Morgan Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure Circ. Res. 61 1987 70 76
43. 31P-magnetic resonance spectroscopy Circulation 86 1992 295 301
44. T. Toyo-oka, W.S. Shin, Y. Okai, Y. Dan, M. Morita, M. Iizuka, and T. Sugimoto Collagen-stimulated human platelet aggregation is mediated by endogenous calcium-activated neutral protease Circ. Res. 64 1989 407 410